Offer - Urjas Oil for just ₹ 1 X
Glynit 6.4 Tablet is a prescription drug, available for use as Tablet. Angina are some of its major therapeutic uses. Glynit 6.4 Tablet also has some secondary and off-label uses. These are listed below.
The optimal dosage of Glynit 6.4 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
The side effects typically associated with Glynit 6.4 Tablet include Dizziness, Weakness, Drowsiness. Apart from the aforementioned side effects, Glynit 6.4 Tablet can also lead to other problems, which have been listed below. Normally, these side effects of Glynit 6.4 Tablet are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
In addition, Glynit 6.4 Tablet's effect is Unknown during pregnancy and Unknown for lactating mothers. In addition, Glynit 6.4 Tablet's effects on the liver, heart and kidney are discussed below in the Glynit 6.4 Tablet related warnings section.
Glynit 6.4 Tablet is contraindicated in people with pre-existing medical conditions like Anemia as it can result in adverse effects. The section on Glynit 6.4 Tablet contraindications lists all such conditions.
Besides this, Glynit 6.4 Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Glynit 6.4 Tablet is not safe while driving, and is is not addictive in nature.
Glynit 6.4 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glynit 6.4 Tablet safe for pregnant women?
No research has been done to ascertain the safety of Glynit in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Is the use of Glynit 6.4 Tablet safe during breastfeeding?
Information about safety of Glynit for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Glynit 6.4 Tablet on the Kidneys?
Glynit is not harmful for kidneys.
What is the effect of Glynit 6.4 Tablet on the Liver?
Information about safety of Glynit for the liver is not available since scientific research on this is yet to be done.
What is the effect of Glynit 6.4 Tablet on the Heart?
Very few cases of side effects of Glynit on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Glynit 6.4 Tablet unless your doctor advises you to do so -
Is this Glynit 6.4 Tablet habit forming or addictive?
No, there is no any evidence that Glynit 6.4 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Glynit 6.4 Tablet. So it is best to avoid driving.
Is it safe?
Glynit 6.4 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Glynit 6.4 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Glynit 6.4 Tablet
Using Glynit 6.4 Tablet with some foods may lead to harmful effects. Take your doctor's advice on this.
Interaction between Alcohol and Glynit 6.4 Tablet
Taking [medicine] and alcohol at the same time may lead to mild side effects. Contact your doctor right away if you observe any side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nitrostat® (Nitroglycerin Sublingual)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540